It's the Brian Lair show on WNYC. Welcome back, everybody. I'm Matt Katz, keeping the seat warm for Brian today.

Unanimous decisions typically allude the Roberts Court, but Thursday saw Rare 9-0.

The heavily right-leaning court rejected an attempt to ban the abortion drug Miffa-Pristone,

concluding that the plaintiffs in the case had no real standing to sue.

Justice Kavanaugh, who delivered the opinion in the case, wrote,

The plaintiffs have sincere, legal, moral, ideological, and policy objections to elective

abortion and to FDA's relaxed regulation of Mephipristone.

But see if you can catch the caveat in this next part of Kavanaugh's opinion.

It is not clear that no one else would have standing to challenge the FDA's relaxed regulation

of Mephyprisone. In other words, the door may yet be open to future challenges to abortion

pills. We'll hear more about the rare unanimous decision in this case, FDA versus Alliance

for Hippocratic Medicine, and we'll hear about some of the other items on the agenda for the Supreme Court before

the end of the term from Donald Trump's claim of immunity from prosecution to misinformation

on social media and more.

My guest is Aziz Huck, Professor of Law at the University of Chicago Law School and author

of the forthcoming, The Rule of Law,

a very short introduction from Oxford University Press. He's writing the book on the rule of law.

Aziz, welcome back to WNYC. Thanks for having me, Matt.

Before we get into what the court did yesterday and what it might do before the conclusion of

this term. I want to start with today's rulings. Today was apparently a very light day, but the

court did issue three rulings, including one that provides an answer to the question of whether

a bump stock meets the statutory definition of a machine gun.

...